文章摘要
Research Progress of Gene Recombination Technology in Genetic Engineering Vaccine of Porcine Pseudorabies Virus
  
DOI:10.16768/j.issn.1004-874X.2021.05.016
Author NameAffiliation
柯海意,王 帅,徐民生,蔡汝健,勾红潮,臧莹安,李春玲,简运华 1. 仲恺农业工程学院动物科技学院广东 广州 510305 2. 广东省农业科学院动物卫生研究所 / 广东省畜禽疫病防治研究重点实验室 / 农业农村部兽用药物与诊断技术广东科学观测实验站广东 广州 510640 3. 茂名市动物疫病控制中心广东 茂名 5250004. 广东广垦畜牧集团股份有限公司广东 广州 510612 
Hits: 1776
Download times: 1130
Abstract:
      Porcine pseudorabies is an acute and highly contagious disease caused by pseudorabies virus (PRV) infection, which can cause disease in pigs of different ages and serious economic losses to the pig industry. One of the main measures to prevent, control and even eradicate porcine pseudorabies is vaccination. It is one of the effective methods to reduce the virulence of PRV or improve the immune protection effect of virus by transforming the key virulence genes of PRV, knocking out the virulence genes or inserting the immune enhancement genes through gene recombination technology, and it is also an important means to develop a safe and efficient genetic engineering vaccine of PRV. The development of porcine PRV genetic engineering vaccine was reviewed from the application of different gene recombination technologies, such as homologous recombination, Cre/loxP site-specific recombination, bacterial artificial chromosome and CRISPR gene editing, with a view to provide references for further study of PRV recombinant vaccine.
View Full Text   View/Add Comment  Download reader